Preparation of Near-Infrared Light Responsive Upconversion Nanoparticles TiO2/(Ca,Y)F2:Tm,Yb for Photodynamic Antitumor Therapy
Huan Zhou,Jie Wang,Bing Yang,Manna Sun,Chunyong Liang,Lei Yang,Xiaoyan Zhao,Hongshui Wang
DOI: https://doi.org/10.1007/s10853-023-08375-w
IF: 4.5
2023-01-01
Journal of Materials Science
Abstract:In this work, near-infrared light responsive upconversion nanoparticles TiO2/(Ca,Y)F2:Tm,Yb were hydrothermally prepared for tumor control. Moreover, femtosecond laser was adopted to reduce particle size and aggregation of TiO2/(Ca,Y)F2:Tm,Yb, as a strategy to enhance its dispersity. In vitro studies of the biocompatibility and tumor control efficacy of TiO2/(Ca,Y)F2:Tm,Yb were carried out via co-culturing human pancreatic carcinoma cells (CFPAC-1). It was found in the absence of near-infrared light, TiO2/(Ca,Y)F2:Tm,Yb showed no toxicity to CFPAC-1 cells. On contrast, when exposed to near-infrared light, particles exhibited irradiation time, irradiation interval and particle concentration dependent suppression of CFPAC-1 cells proliferation along with portion of S phase cells increase. A nude mouse model with CFPAC-1 cells injection was established and TiO2/(Ca,Y)F2:Tm,Yb was subsequently applied for in vivo tumor control. A 15 days tracking confirmed the antitumor capability of near-infrared light excited TiO2/(Ca,Y)F2:Tm,Yb. Overall, we anticipate that the here-introduced TiO2/(Ca,Y)F2:Tm,Yb can serve as an effective agent for photodynamic antitumor therapy.